Literature DB >> 11514129

Co-morbidity of personality disorders in individuals with substance use disorders.

R Verheul1.   

Abstract

This review summarizes the recent literature about personality disorders among substance abusers. First, it will be shown that personality disorders are highly prevalent co-morbid conditions among addicted individuals. Second, it is argued that this co-morbidity is likely to be accounted for by multiple complex etiological relationships. Finally, the clinical relevance of routine assessment of (maladaptive) personality traits in individuals admitting for substance abuse treatment will be discussed.

Entities:  

Mesh：

Year:  2001        PMID： 11514129     DOI： 10.1016/s0924-9338(01)00578-8

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN： 0924-9338            Impact factor:   5.361


  41 in total

Review 1.  Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse.

Authors:  Antonio Verdejo-García; Francisca López-Torrecillas; Carmen Orozco Giménez; Miguel Pérez-García
Journal:  Neuropsychol Rev       Date:  2004-03       Impact factor: 7.444

Review 2.  Gene-environment interplay in alcoholism and other substance abuse disorders: expressions of heritability and factors influencing vulnerability.

Authors:  Tomas Palomo; R M Kostrzewa; R J Beninger; T Archer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

3.  Probability and predictors of remission from life-time nicotine, alcohol, cannabis or cocaine dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Catalina Lopez-Quintero; Deborah S Hasin; José Pérez de Los Cobos; Abigail Pines; Shuai Wang; Bridget F Grant; Carlos Blanco
Journal:  Addiction       Date:  2010-11-16       Impact factor: 6.526

4.  The differential effects of ecstasy/polydrug use on executive components: shifting, inhibition, updating and access to semantic memory.

Authors:  Catharine Montgomery; John E Fisk; Russell Newcombe; Phillip N Murphy
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

5.  Screening for personality disorders.

Authors:  Jennifer Q Morse; Paul A Pilkonis
Journal:  J Pers Disord       Date:  2007-04

6.  Basal functioning of the hypothalamic-pituitary-adrenal (HPA) axis and psychological distress in recreational ecstasy polydrug users.

Authors:  Mark A Wetherell; Catharine Montgomery
Journal:  Psychopharmacology (Berl)       Date:  2013-11-05       Impact factor: 4.530

7.  Mentalization-Based Treatment for Concurrent Borderline Personality Disorder and Substance Use Disorder: A Randomized Controlled Feasibility Study.

Authors:  Björn Philips; Peter Wennberg; Per Konradsson; Johan Franck
Journal:  Eur Addict Res       Date:  2018-01-19       Impact factor: 3.015

Review 8.  [Evidence-based psychotherapy: addiction and personality disorders as comorbidities].

Authors:  T Kienast; E Roediger; M Kensche; J Foerster; I Daig; A Heinz
Journal:  Nervenarzt       Date:  2009-09       Impact factor: 1.214

9.  Negative affect and emotion dysregulation among people who inject drugs: An ecological momentary assessment study.

Authors:  Mary Ellen Mackesy-Amiti; Geri Donenberg
Journal:  Psychol Addict Behav       Date:  2020-04-09

10.  Impact of co-occurring psychiatric disorders on retention in a methadone maintenance program: an 18-month follow-up study.

Authors:  Mònica Astals; Laura Díaz; Antònia Domingo-Salvany; Rocío Martín-Santos; Antoni Bulbena; Marta Torrens
Journal:  Int J Environ Res Public Health       Date:  2009-11-12       Impact factor: 3.390
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.